Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
As a result of the investment in cancer research, NCI was in a strong position to make key early advances in the fight against HIV/AIDS.
Funding will support research on conditions including fatty liver disease, liver cancer, asthma and chronic kidney disease.
Researchers sought to debunk a longstanding racial medical myth.
Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.
“Over 40% of the vulnerable population in the U.S. lives within 5 miles of a CVS Pharmacy location, so we have a chance to engage them.”
Infection with EBV dramatically increased the odds of developing multiple sclerosis, suggesting vaccines could help prevent it.
A law says any biological materials remaining after diagnostic procedures may be used for research—usually without an individual’s consent.
Collins has led the NIH under three presidents over more than 12 years.
Researchers attribute disparities in mortality rates to COVID-19–related deaths and persistent health inequities.
The Hispanic/Latino Cancer Survivorship Study will unpack the cultural, biological and medical influences on post-cancer life.
The Senate-passed bill memorializing Henrietta Lacks aims to address underrepresentation in cancer clinical trials.
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.
Infectious disease researchers worry about their ability to continue working as supplies of N95 respirators dwindle.
Can data from more than 1 million Americans accelerate research and medical breakthroughs that benefit everyone?
Why does the world’s most common liver virus affect humans more than our most recent genetic ancestors?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.